Vol 60, No 3 (2004)
Other
Published online: 2005-12-12
Submitted: 2012-12-28
Get Citation

Risk factors of atrial fibrillation in patients with Wolff-Parkinson-White syndrome

Łukasz Szumowski, Franciszek Walczak, Piotr Urbanek, Ewa Szufladowicz, Ewa Ratajska, Roman Kępski, Ewa Bujnowska, Robert Bodalski, Paweł Derejko, Waldemar Łabędź
Kardiol Pol 2004;60(3):212-216.
Vol 60, No 3 (2004)
Other
Published online: 2005-12-12
Submitted: 2012-12-28

Abstract

Background: Atrial fibrillation (AF) in patients with WPW syndrome may be a life-threatening arrhythmia.
Aim: To identify risk factors of AF and their prognostic significance in patients with WPW syndrome.
Methods: Clinical and electrophysiological parameters of 239 patients with WPW syndrome, who underwent successful RF ablation, were analysed using logistic regression and multivariate analysis. One hundred eight patients had no history of AF whereas the remaining 81 patients had previous spontaneous AF episodes. Long-term follow-up data (mean 29±23 months, range 1-99 months) were available in 136 patients (87 without AF and 49 with AF).
Results: Patients with AF were significantly older, more frequently of male gender and had more often a history of syncope than patients without AF. There were two peaks of AF occurrence - in the third and in the fifth decade of life. Fourteen patients had a history of ventricular fibrillation - 11 patients with AF vs 3 patients without AF (p=0.0016). Patients with a history of AF were more prone to AF induced during electrophysiological study and had less frequently concealed accessory pathways.
Conclusions: Age, gender and a history of syncope are the independent risk factors of AF in patients with WPW syndrome. Anterograde conduction via accessory pathway is of major importance in the development of AF. RF ablation of an accessory pathway should be performed early because the risk of the procedure is small and there is an increasing risk of AF with ageing.

Abstract

Background: Atrial fibrillation (AF) in patients with WPW syndrome may be a life-threatening arrhythmia.
Aim: To identify risk factors of AF and their prognostic significance in patients with WPW syndrome.
Methods: Clinical and electrophysiological parameters of 239 patients with WPW syndrome, who underwent successful RF ablation, were analysed using logistic regression and multivariate analysis. One hundred eight patients had no history of AF whereas the remaining 81 patients had previous spontaneous AF episodes. Long-term follow-up data (mean 29±23 months, range 1-99 months) were available in 136 patients (87 without AF and 49 with AF).
Results: Patients with AF were significantly older, more frequently of male gender and had more often a history of syncope than patients without AF. There were two peaks of AF occurrence - in the third and in the fifth decade of life. Fourteen patients had a history of ventricular fibrillation - 11 patients with AF vs 3 patients without AF (p=0.0016). Patients with a history of AF were more prone to AF induced during electrophysiological study and had less frequently concealed accessory pathways.
Conclusions: Age, gender and a history of syncope are the independent risk factors of AF in patients with WPW syndrome. Anterograde conduction via accessory pathway is of major importance in the development of AF. RF ablation of an accessory pathway should be performed early because the risk of the procedure is small and there is an increasing risk of AF with ageing.
Get Citation

Keywords

atrial fibrillation - wpw syndrome - risk factors

About this article
Title

Risk factors of atrial fibrillation in patients with Wolff-Parkinson-White syndrome

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 60, No 3 (2004)

Pages

212-216

Published online

2005-12-12

Bibliographic record

Kardiol Pol 2004;60(3):212-216.

Keywords

atrial fibrillation - wpw syndrome - risk factors

Authors

Łukasz Szumowski
Franciszek Walczak
Piotr Urbanek
Ewa Szufladowicz
Ewa Ratajska
Roman Kępski
Ewa Bujnowska
Robert Bodalski
Paweł Derejko
Waldemar Łabędź

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl